Status:
NOT_YET_RECRUITING
Effects of Whole-body Electrostimulation on Patients With Chronic Kidney Disease
Lead Sponsor:
Federal University of Health Science of Porto Alegre
Collaborating Sponsors:
Leonhardt Ventures LLC
Conditions:
Renal Insufficiency, Chronic
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic kidney disease (CKD) consists of kidney damage, with consequent progressive and irreversible loss of kidney function. In the early stages of the disease, a reduction in circulating levels of t...
Detailed Description
Patients with stage III and IV chronic kidney disease will be randomized into two groups, one group will receive whole-body electrical stimulation and the other group will be a control group (it will ...
Eligibility Criteria
Inclusion
- Patients diagnosed with CKD (≥ 3 months) in stages 3-4 (GFR between 59 and 15 ml/min/1.73m2);
- Age between 18 and 80 years old;
- Functional capacity ≥ 300 meters in the six-minute walk test.
Exclusion
- Cognitive dysfunction that prevents assessments from being carried out or inability to understand and sign the informed consent form;
- Intolerance to electrical stimulator and/or changes in skin sensitivity;
- Skin injuries or burns where the electrodes are positioned;
- Patients with stroke sequelae;
- Recent acute myocardial infarction (two months);
- Uncontrolled hypertension (SBP\>230 mmHg and DBP\>120 mmHg);
- New York Heart Association grade IV heart failure or decompensated;
- Unstable angina or arrhythmia;
- Artificial cardiac pacemaker or implantable cardioverter defibrillator;
- Peripheral vascular changes in the lower limbs such as deep vein thrombosis;
- Disabling osteoarticular or musculoskeletal disease;
- Uncontrolled diabetes (glycemia \> 300mg/dL);
- Patients with cancer and/or undergoing oncological treatment;
- Epilepsy;
- Hemophilia;
- Chronic obstructive pulmonary disease;
- Grade II obesity (BMI≥35).
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06502522
Start Date
August 1 2024
End Date
March 1 2025
Last Update
July 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.